The use of ipratropium bromide for treating moderate to severe asthma exacerbations in pediatric patients in an emergency setting: A cost‐effectiveness analysis-Reference-Cited by-同舟云学术

The use of ipratropium bromide for treating moderate to severe asthma exacerbations in pediatric patients in an emergency setting: A cost‐effectiveness analysis

Published:2021-09-02 Issue:12 Volume:56 Page:3706-3713
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Rodriguez‐Martinez Carlos E.¹²^ORCID,Sossa‐Briceño Monica P.³,Buendia Jefferson Antonio⁴^ORCID

Affiliation:

1. Department of Pediatrics, School of Medicine Universidad Nacional de Colombia Bogota Colombia

2. Department of Pediatric Pulmonology, School of Medicine Universidad El Bosque Bogota Colombia

3. Department of Internal Medicine, School of Medicine Universidad Nacional de Colombia Bogotá Colombia

4. Department of Pharmacology and Toxicology, School of Medicine, Research Group in Pharmacology and Toxicology (INFARTO) Universidad de Antioquia Medellín Colombia

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.25648

Reference27 articles.

1. Global burden of asthma among children

2. Asthma costs and social impact

3. Direct medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income country

4. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2021. Available from:www.ginasthma.org(Accessed May 11thy 2021).

5. Treatment of acute asthma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric pulmonology 2021 year in review: Asthma;Pediatric Pulmonology;2022-12-30